8.99
Kiora Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
7.68
FY23:
4.74
FY24:
29.7
FY25:
21.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.1
FY22:
11.0
FY23:
8.97
FY24:
6.78
FY25:
2.50
Total assets
Change from FY21 to FY25
millions USD
FY21:
20.1
FY22:
18.7
FY23:
13.7
FY24:
36.5
FY25:
24.3
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.61
FY22:
3.27
FY23:
1.63
FY24:
6.01
FY25:
3.63
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.94
FY22:
4.00
FY23:
5.97
FY24:
4.72
FY25:
4.50
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.6
FY22:
11.4
FY23:
6.11
FY24:
25.8
FY25:
16.1
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
20.1
FY22:
18.7
FY23:
13.7
FY24:
36.5
FY25:
24.3
All amounts in millions USD